PDS Biotechnology Corpora... (PDSB)
NASDAQ: PDSB
· Real-Time Price · USD
1.24
0.05 (4.20%)
At close: Aug 18, 2025, 3:59 PM
1.22
-1.61%
After-hours: Aug 18, 2025, 06:06 PM EDT
4.20% (1D)
| Bid | 1.21 |
| Market Cap | 56.68M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -35.5M |
| EPS (ttm) | -0.91 |
| PE Ratio (ttm) | -1.36 |
| Forward PE | -1.28 |
| Analyst | Buy |
| Ask | 1.24 |
| Volume | 366,458 |
| Avg. Volume (20D) | 601,938 |
| Open | 1.22 |
| Previous Close | 1.19 |
| Day's Range | 1.19 - 1.25 |
| 52-Week Range | 0.85 - 4.29 |
| Beta | 0.94 |
About PDSB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PDSB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PDSB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-0.63%
PDS Biotechnology shares are trading higher after ...
Unlock content with
Pro Subscription
5 months ago
-8.21%
PDS Biotechnology shares are trading higher after the company announced the initiation of its VERSATILE-003 Phase 3 clinical trial.
